Completed OBSERVATIONAL NCT01219257

Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy (ULSPABIT)

Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting First Time or Switching to a New Biological Therapy; the ULSpABiT Study.

Sponsor: Diakonhjemmet Hospital

Conditions Spondyloarthritis Ultrasonography

Interventions Anti-TNF alpha therapy

Updated 11 times since 2017 Last updated: Aug 1, 2022 Started: Sep 30, 2011 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Spondyloarthritis and Ultrasonography and is currently completed. Diakonhjemmet Hospital leads this study, which shows 11 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2022 — Jul 2024 [monthly]

Completed
Dec 2021 — Sep 2022 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed

▶ Show 6 earlier versions

Nov 2020 — Jan 2021 [monthly]

Completed
Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Sep 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diakonhjemmet Hospital

Data source: Diakonhjemmet Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway